Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 171

Sort by

Sort Order Select

Journal Articles

Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial

Blood (2024) 144 (Supplement 1): 224.

https://doi.org/10.1182/blood-2024-201694

Published: 2024

Journal Articles

DNA Hypomethylation Is Not Sufficient to Account for Decitabine Mediated Cytotoxicity in TP53 -Mutated Myeloid Malignancies

Jeremy T. Baeten, Sumedha Agashe, Annabel Quinet, Jamie Butler, Amber C. Carter, Jack Wooldridge, Kimberly Johansson, Geoffrey L. Uy, Alessandro Vindigni, Daniel C. Link

Blood (2024) 144 (Supplement 1): 5783.

https://doi.org/10.1182/blood-2024-211001

Published: 2024

Journal Articles

JAK2-V617F Expression Results in a Cell-Intrinsic Expansion of Megakaryocyte Progenitors with Evidence of Myc Pathway Activation in Both Mature and Precursor Megakaryocytes By Single Cell RNA Sequencing

Joshua Siner, Jun Xia, Juo-Chin Yao, Kartik Singhal, Daniel Fisher, Lilian Antunes Heck, Malachi Griffith, Stephen Oh, Jorge Di Paola, Daniel C. Link

Blood (2024) 144 (Supplement 1): 6567.

https://doi.org/10.1182/blood-2024-211373

Published: 2024

Journal Articles

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Jeremy T. Baeten, Irenaeus C.C. Chan, Lea Moukarzel, Amber C. Carter, Minal Patel, Konrad H. Stopsack, Paul Pharoah, James Brenton, Bob T Li, Wassim Abida, Alison M. Schram, Karen Cadoo, Britta Weigelt, Carlos Cruchaga, Howard Scher, Ross L Levine, Elli Papaemmanuil, Daniel C. Link, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 1315.

https://doi.org/10.1182/blood-2023-190457

Published: 2023

Journal Articles

Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm

J. Scott Beeler, Duc Tran, Jie Liu, Zilan Xin, Brian Wiley, Irenaeus C.C. Chan, Michael H. Kramer, Armel L. Batchi-Bouyou, Xiaoyu Zong, Matthew J. Walter, Sarantis Chlamydas, Francesca Ferraro, Stephen T. Oh, Ben Busby, Daniel C. Link, Yin Cao, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 940.

https://doi.org/10.1182/blood-2023-190857

Published: 2023

Journal Articles

Idasanutlin and Navitoclax Induce a Synergistic p53-Dependent Apoptotic Cell Death in T-Cell Acute Lymphoblastic Leukemia

Kimberly Johansson, Iryna V Dmytrenko, Megan Gauthier, Feng Gao, Daniel C. Link

Blood (2023) 142 (Supplement 1): 1450.

https://doi.org/10.1182/blood-2023-190018

Published: 2023

Journal Articles

Srcap Plays an Essential Role in Normal Hematopoiesis

Terrence Wong, Anna Mykalowych, Alexander Carson, Daniel C. Link

Blood (2023) 142 (Supplement 1): 4052.

https://doi.org/10.1182/blood-2023-180149

Published: 2023

Journal Articles

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Jie Liu, Duc Tran, Irenaeus C.C. Chan, Brian Wiley, Caroline Watson, Armel L. Batchi-Bouyou, Xiaoyu Zong, Konrad H. Stopsack, Paul Pharoah, Li Ding, Jamie R Blundell, Yin Cao, Matthew J. Walter, Nilanjan Chatterjee, Kenneth Offit, Lucy Godley, Daniel C. Link, Zsofia Stadler, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 811.

https://doi.org/10.1182/blood-2023-182423

Published: 2023

Journal Articles

Nucleolar Stress Plays a Key Role in the Pathogenesis of T Cell Acute Lymphoblastic Leukemia

Joseph R. Krambs, Kimberly B. Johansson, Isabelle Genter, Sai Mukund Ramakrishnan, Christopher A Miller, Daniel C. Link

Blood (2022) 140 (Supplement 1): 5891–5892.

https://doi.org/10.1182/blood-2022-158717

Published: 2022

Journal Articles

Arcch: Improving the Performance of Clonal Hematopoiesis Variant Calling and Interpretation Using a Consensus Based Approach

Evelyn L Schmidt, Irenaeus C.C. Chan, Alex Panchot, Brian Wiley, Jie Liu, Lea Moukarzel, Yiwen Zhang, Daniel C. Link, Konrad Stopsack, Kelly L Bolton

Blood (2022) 140 (Supplement 1): 5762–5763.

https://doi.org/10.1182/blood-2022-170221

Published: 2022

Journal Articles

Targeting ATR in TP53 -Mutant AML/MDS

Jeremy T Baeten, Sumedha Agashe, Annabel Quinet, Kimberly B. Johansson, Alessandro Vindigni, Geoffrey L. Uy, Daniel C. Link

Blood (2022) 140 (Supplement 1): 8787–8788.

https://doi.org/10.1182/blood-2022-170238

Published: 2022

Journal Articles

Idasanutlin and Navitoclax Induce Synergistic Apoptotic Cell Death in T-Cell Acute Lymphoblastic Leukemia

Kimberly B. Johansson, Megan Gauthier, Feng Gao, Daniel C. Link

Blood (2022) 140 (Supplement 1): 3262–3263.

https://doi.org/10.1182/blood-2022-167220

Published: 2022

Journal Articles

IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function

Sidan Li, Juo-Chin Yao, Karolyn A. Oetjen, Joseph R. Krambs, Jun Xia, Jingzhu Zhang, Amy P. Schmidt, Nichole M. Helton, Robert S. Fulton, Sharon E. Heath, Isaiah R. Turnbull, Gabriel Mbalaviele, Timothy J. Ley, Matthew J. Walter, Daniel C. Link

Blood (2022) 140 (14): 1607–1620.

https://doi.org/10.1182/blood.2022016084

Published: 2022

Includes: Supplemental data

Journal Articles

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

Michael H. Kramer, Qiang Zhang, Robert Sprung, Ryan B. Day, Petra Erdmann-Gilmore, Yang Li, Ziheng Xu, Nichole M. Helton, Daniel R. George, Yiling Mi, Peter Westervelt, Jacqueline E. Payton, Sai M. Ramakrishnan, Christopher A. Miller, Daniel C. Link, John F. DiPersio, Matthew J. Walter, R. Reid Townsend, Timothy J. Ley

Blood (2022) 140 (13): 1533–1548.

https://doi.org/10.1182/blood.2022016033

Published: 2022

Includes: Supplemental data

Journal Articles

Heterozygous variants of CLPB are a cause of severe congenital neutropenia

Julia T. Warren, Ryan R. Cupo, Peeradol Wattanasirakul, David H. Spencer, Adam E. Locke, Vahagn Makaryan, Audrey Anna Bolyard, Merideth L. Kelley, Natalie L. Kingston, James Shorter, Christine Bellanné-Chantelot, Jean Donadieu, David C. Dale, Daniel C. Link

Blood (2022) 139 (5): 779–791.

https://doi.org/10.1182/blood.2021010762

Published: 2022

Includes: Supplemental data

Journal Articles

Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression

Blood (2021) 138 (Supplement 1): 800.

https://doi.org/10.1182/blood-2021-148645

Published: 2021

Journal Articles

Analysis of the Proteomes of Primary, De Novo Acute Myeloid Leukemia Cells from Adults

Michael H Kramer, Qiang Zhang, Robert W. Sprung, Petra Erdmann-Gilmore, Daniel R George, Nichole M Helton, Sharon E Heath, Jacqueline E. Payton, Peter Westervelt, Christopher A Miller, Matthew J. Walter, Daniel C. Link, John F. DiPersio, R Reid Townsend, Timothy J Ley

Blood (2021) 138 (Supplement 1): 3427.

https://doi.org/10.1182/blood-2021-148819

Published: 2021

Journal Articles

Microbiota Signals Suppress the Lymphoid Specification of Hematopoietic Stem Cells

Joseph R. Krambs, Darlene A. Monlish, Feng Gao, Laura G. Schuettpelz, Daniel C. Link

Blood (2021) 138 (Supplement 1): 204.

https://doi.org/10.1182/blood-2021-151369

Published: 2021

Journal Articles

Effects of PARP Inhibitor Therapy on p53-Deficient Hematopoietic Stem and Progenitor Cell Fitness

Jeremy T Baeten, Irenaeus C.C. Chan, Daniel C. Link, Kelly L. Bolton

Blood (2021) 138 (Supplement 1): 3275.

https://doi.org/10.1182/blood-2021-151373

Published: 2021

Journal Articles

TGF-β Signaling in Stromal Cells Contributes to Myelofibrosis, but Not Niche Disruption, in Myeloproliferative Neoplasms

Juo-Chin Yao, Daniel C. Link

Blood (2021) 138 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2021-148776

Published: 2021

NARROW

Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial

DNA Hypomethylation Is Not Sufficient to Account for Decitabine Mediated Cytotoxicity in TP53 -Mutated Myeloid Malignancies

JAK2-V617F Expression Results in a Cell-Intrinsic Expansion of Megakaryocyte Progenitors with Evidence of Myc Pathway Activation in Both Mature and Precursor Megakaryocytes By Single Cell RNA Sequencing

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm

Idasanutlin and Navitoclax Induce a Synergistic p53-Dependent Apoptotic Cell Death in T-Cell Acute Lymphoblastic Leukemia

Srcap Plays an Essential Role in Normal Hematopoiesis

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Nucleolar Stress Plays a Key Role in the Pathogenesis of T Cell Acute Lymphoblastic Leukemia

Arcch: Improving the Performance of Clonal Hematopoiesis Variant Calling and Interpretation Using a Consensus Based Approach

Targeting ATR in TP53 -Mutant AML/MDS

Idasanutlin and Navitoclax Induce Synergistic Apoptotic Cell Death in T-Cell Acute Lymphoblastic Leukemia

IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

Heterozygous variants of CLPB are a cause of severe congenital neutropenia

Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression

Analysis of the Proteomes of Primary, De Novo Acute Myeloid Leukemia Cells from Adults

Microbiota Signals Suppress the Lymphoid Specification of Hematopoietic Stem Cells

Effects of PARP Inhibitor Therapy on p53-Deficient Hematopoietic Stem and Progenitor Cell Fitness

TGF-β Signaling in Stromal Cells Contributes to Myelofibrosis, but Not Niche Disruption, in Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only